Abstract
Objective
The objectives of this retrospective study were to examine the relationship between the bioavailability of itraconazole and the type of food consumed and to determine the effects of food consumption on the pharmacokinetic parameters following a single oral dose of itraconazole in healthy volunteers.
Methods
The plasma itraconazole concentration-time data were pooled from four pharmacokinetic studies in 144 healthy subjects. Individual pharmacokinetic values were estimated as model-independent (AUC, C max, and T max) and model-dependent (T lag, K a, K cp, K pc, K el, and V d/F; two-compartment open model with lag time) parameters using the WinNonlin software program. We estimated the population characteristics of the food effects using NONMEM.
Results
The consumption of a bread meal before the administration of itraconazole caused a significant increase in its bioavailability, as well as increases in the peak plasma concentration and lag time for itraconazole absorption. On the contrary, consumption of a rice meal before the administration of itraconazole caused a significant decrease in its bioavailability.
Conclusion
Therefore, although a dose of itraconazole is normally administered immediately after a meal to increase its bioavailability, this is not an effective strategy after a rice meal.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wong JW, Nisar UR, Yuen KH (2003) Liquid chromatographic method for the determination of plasma itraconazole and its metabolite in pharmacokinetic/bioavailability studies. J Chromatogr B 798:355–360
Yoo SD, Kang EH, Shin BS, Lee KC, Lee KH (2000) Absorption, first-pass metabolism, and disposition of itraconazole in rats. Chem Pharm Bull 48:798–801
Van de Velde VJ, Van Peer AP, Heykants JJ, Woestenborghs RJ, Van rooy P, De Beule KL, Cauwenbergh GF (1996) Effect of food on the pharmacokinetics of new hydroxypropyl-β-cyclodextrin formulation of itraconazole. Pharmacotherapy 16:424–428
Poirer JM, Cheymol G (1998) Optimisation of itraconazole therapy using target drug concentrations. Clin Pharmacokinet 35:461–473
Koks CH, Huitema AD, Kroon ED, Chuenyam T, Sparidans RW, Lange JM, Beijnen JH (2003) Population pharmacokinetics of itraconazole in Thai HIV-1-infected persons. Ther Drug Monit 25:229–233
Van de Velde VJ, Van Peer AP, Heykants JJ, Woestenborghs RJ, Van rooy P, De Beule KL, Cauwenbergh GF (1989) The clinical pharmacokinetics of itraconazole: an overview. Mycoses 32:67–88
Karel DB (1996) Itraconazole: pharmacology, clinical experience and future development. Int J Antimicrob Agents 6:175–181
Boelaert J, Schurgers M, Matthys E, Daneels R, Van Peer A, De Beule K, Woestenborghs R, Heykants J (1988) Itraconazole pharmacokinetics in patients with renal dysfunction. Antimicorb Agents Chemother 32:178–180
Elaine MB, David JK, Micheal JR (1990) The triazole antifungal agents: a review of itraconazole and fluconazole. Pharmacotherapy 10:146–153
Boeckmann A, Sheiner L, Beal S (1992) NONMEM users’ guide. GloboMax, California
Park HM, Kang SS, Lee YB, Shi DJ, Kim ON, Lee SB, Yim DS (2002) Population pharmacokinetics of intravenous valproic acid in Korean patients. J Clin Pharm Ther 27:419–425
Lake-Bakaar G, Tom W, Gupta N, Beidas S, Elsker M, Shaus EW (1988) Reversible ketoconazole malabsorption. Gastroenterology 94:A247
Suntherland C (1988) The effects of gastric acidifying agents on the pharmacokinetics of ketoconazole (abstract). American Society of Hospital Pharmacists Proceedings, Atlanta, p 297
Scott R, Paul O, Bill J, Peiling W, Micheal S (1999) Grapefruit juice decreases the systemic availability of itraconazole capsules in healthy volunteers. Ther Drug Monit 21:304–312
Zimmermann T, Veates RA, Laufen H, Pfaff G, Wildfeuer A (1994) Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole. Eur J Clin Pharmacol 46:147–150
Mayer JH (1987) Motility of the stomach and gastroduodenal junction. Physiology of the gastrointestinal tract, 2nd edn. Raven, New York
David L, Jannifer HP, Jane W, Mark K (1997) Effect of a cola beverage on the bioavailability of itraconazole in the presence of H2 blocker. J Clin Pharmacol 37:535–540
Hurley WL. Milk composition. Department of Animal Sciences, University of Illinois (online). Available from http://classes.aces.uiuc.edu/AnSci308/
Yun HY, Lee EJ, Chung SY, Choi SO, Kim HK, Kwon JT, Kang WK, Kwan KI (2006) The effects of food on the bioavailability of fenofibrate administered orally via sustained-release capsules in humans. Clin Pharmacokinet 45(4):425–432
Amiodon GL, Lennernas H, Shah VP, Crison JR (1995) A theoretical basis for a biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharma Res 12:413–420
Sunesen VH, Vedelsdal R, Kristensen HG, Christrup L, Mullertz A (2005) Effect of liquid volume and food intake on the absolute bioavailability of danzol, a poorly soluble drug. Eur J Pharm Sci 24:297–303
Archibald GP, Axel G. (2005) Making sense of itraconazole pharmacokinetics. J Antimicrob Chemother 56:i17–i22
Acknowledgment
This study was supported by a grant from the Korea Food and Drug Administration (KFDA).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yun, Hy., Baek, M.S., Park, I.S. et al. Comparative analysis of the effects of rice and bread meals on bioavailability of itraconazole using NONMEM in healthy volunteers. Eur J Clin Pharmacol 62, 1033–1039 (2006). https://doi.org/10.1007/s00228-006-0200-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-006-0200-5